United States Indoleamine 2,3 Dioxygenase 1 Market Report 2017

December 2017 | 109 pages | ID: U8C82628931EN
QYResearch

Abstracts

In this report, the United States Indoleamine 2,3 Dioxygenase 1 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Indoleamine 2,3 Dioxygenase 1 in these regions, from 2012 to 2022 (forecast).

United States Indoleamine 2,3 Dioxygenase 1 market competition by top manufacturers/players, with Indoleamine 2,3 Dioxygenase 1 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• BirchBioMed Inc
• Bristol-Myers Squibb Company
• Ensemble Therapeutics Corp
• F. Hoffmann-La Roche Ltd
• Genentech Inc
• Globavir Biosciences Inc
• Incyte Corp
• IO Biotech ApS
• Kyowa Hakko Kirin
• Netherlands Translational Research Center BV
• NewLink Genetics Corp
• Pfizer Inc
• Redx Pharma Plc
• Regen BioPharma Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• BMS-986205
• Dcellvax
• Epacadostat
• F-001287
• Galanal
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Aolpecia
• Cervical Cancer
• Gastric Cancer
• Glioma
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Indoleamine 2,3 Dioxygenase 1 Market Report 2017

1 INDOLEAMINE 2,3 DIOXYGENASE 1 OVERVIEW

1.1 Product Overview and Scope of Indoleamine 2,3 Dioxygenase
1.2 Classification of Indoleamine 2,3 Dioxygenase 1 by Product Category
  1.2.1 United States Indoleamine 2,3 Dioxygenase 1 Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Indoleamine 2,3 Dioxygenase 1 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 BMS-986205
  1.2.4 Dcellvax
  1.2.5 Epacadostat
  1.2.6 F-001287
  1.2.7 Galanal
  1.2.8 Others
1.3 United States Indoleamine 2,3 Dioxygenase 1 Market by Application/End Users
  1.3.1 United States Indoleamine 2,3 Dioxygenase 1 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Aolpecia
  1.3.3 Cervical Cancer
  1.3.4 Gastric Cancer
  1.3.5 Glioma
  1.3.6 Others
1.4 United States Indoleamine 2,3 Dioxygenase 1 Market by Region
  1.4.1 United States Indoleamine 2,3 Dioxygenase 1 Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
  1.4.3 Southwest Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
  1.4.5 New England Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
  1.4.6 The South Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
  1.4.7 The Midwest Indoleamine 2,3 Dioxygenase 1 Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Indoleamine 2,3 Dioxygenase 1 (2012-2022)
  1.5.1 United States Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2012-2022)
  1.5.2 United States Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2012-2022)

2 UNITED STATES INDOLEAMINE 2,3 DIOXYGENASE 1 MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Indoleamine 2,3 Dioxygenase 1 Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Indoleamine 2,3 Dioxygenase 1 Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Indoleamine 2,3 Dioxygenase 1 Average Price by Players/Suppliers (2012-2017)
2.4 United States Indoleamine 2,3 Dioxygenase 1 Market Competitive Situation and Trends
  2.4.1 United States Indoleamine 2,3 Dioxygenase 1 Market Concentration Rate
  2.4.2 United States Indoleamine 2,3 Dioxygenase 1 Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Indoleamine 2,3 Dioxygenase 1 Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INDOLEAMINE 2,3 DIOXYGENASE 1 SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Region (2012-2017)
3.2 United States Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Region (2012-2017)
3.3 United States Indoleamine 2,3 Dioxygenase 1 Price by Region (2012-2017)

4 UNITED STATES INDOLEAMINE 2,3 DIOXYGENASE 1 SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Type (2012-2017)
4.3 United States Indoleamine 2,3 Dioxygenase 1 Price by Type (2012-2017)
4.4 United States Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Type (2012-2017)

5 UNITED STATES INDOLEAMINE 2,3 DIOXYGENASE 1 SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Application (2012-2017)
5.2 United States Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES INDOLEAMINE 2,3 DIOXYGENASE 1 PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 BirchBioMed Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
  6.2.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Ensemble Therapeutics Corp
  6.3.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 F. Hoffmann-La Roche Ltd
  6.4.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Genentech Inc
  6.5.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Globavir Biosciences Inc
  6.6.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Incyte Corp
  6.7.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 IO Biotech ApS
  6.8.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Kyowa Hakko Kirin
  6.9.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Netherlands Translational Research Center BV
  6.10.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 NewLink Genetics Corp
6.12 Pfizer Inc
6.13 Redx Pharma Plc
6.14 Regen BioPharma Inc

7 INDOLEAMINE 2,3 DIOXYGENASE 1 MANUFACTURING COST ANALYSIS

7.1 Indoleamine 2,3 Dioxygenase 1 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Indoleamine 2,3 Dioxygenase

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Indoleamine 2,3 Dioxygenase 1 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Indoleamine 2,3 Dioxygenase 1 Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INDOLEAMINE 2,3 DIOXYGENASE 1 MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Indoleamine 2,3 Dioxygenase 1 Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Indoleamine 2,3 Dioxygenase 1 Sales Volume Forecast by Type (2017-2022)
11.3 United States Indoleamine 2,3 Dioxygenase 1 Sales Volume Forecast by Application (2017-2022)
11.4 United States Indoleamine 2,3 Dioxygenase 1 Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Indoleamine 2,3 Dioxygenase
Figure United States Indoleamine 2,3 Dioxygenase 1 Market Size (K Pcs) by Type (2012-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Volume Market Share by Type (Product Category) in 2016
Figure BMS-986205 Product Picture
Figure Dcellvax Product Picture
Figure Epacadostat Product Picture
Figure F-001287 Product Picture
Figure Galanal Product Picture
Figure Others Product Picture
Figure United States Indoleamine 2,3 Dioxygenase 1 Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Indoleamine 2,3 Dioxygenase 1 by Application in 2016
Figure Aolpecia Examples
Table Key Downstream Customer in Aolpecia
Figure Cervical Cancer Examples
Table Key Downstream Customer in Cervical Cancer
Figure Gastric Cancer Examples
Table Key Downstream Customer in Gastric Cancer
Figure Glioma Examples
Table Key Downstream Customer in Glioma
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Indoleamine 2,3 Dioxygenase 1 Market Size (Million USD) by Region (2012-2022)
Figure The West Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Indoleamine 2,3 Dioxygenase 1 Sales Share by Players/Suppliers
Figure 2017 United States Indoleamine 2,3 Dioxygenase 1 Sales Share by Players/Suppliers
Figure United States Indoleamine 2,3 Dioxygenase 1 Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Indoleamine 2,3 Dioxygenase 1 Revenue Share by Players/Suppliers
Figure 2017 United States Indoleamine 2,3 Dioxygenase 1 Revenue Share by Players/Suppliers
Table United States Market Indoleamine 2,3 Dioxygenase 1 Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Indoleamine 2,3 Dioxygenase 1 Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Indoleamine 2,3 Dioxygenase 1 Market Share of Top 3 Players/Suppliers
Figure United States Indoleamine 2,3 Dioxygenase 1 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Indoleamine 2,3 Dioxygenase 1 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Indoleamine 2,3 Dioxygenase 1 Product Category
Table United States Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs) by Region (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Sales Share by Region (2012-2017)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Share by Region (2012-2017)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Region in 2016
Table United States Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Revenue Share by Region (2012-2017)
Figure United States Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region (2012-2017)
Figure United States Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region in 2016
Table United States Indoleamine 2,3 Dioxygenase 1 Price (USD/Pcs) by Region (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs) by Type (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Sales Share by Type (2012-2017)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Share by Type (2012-2017)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type in 2016
Table United States Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Indoleamine 2,3 Dioxygenase 1 by Type (2012-2017)
Figure Revenue Market Share of Indoleamine 2,3 Dioxygenase 1 by Type in 2016
Table United States Indoleamine 2,3 Dioxygenase 1 Price (USD/Pcs) by Types (2012-2017)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Type (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs) by Application (2012-2017)
Table United States Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2012-2017)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2012-2017)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application in 2016
Table United States Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Application (2012-2017)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Application (2012-2017)
Table BirchBioMed Inc Basic Information List
Table BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (2012-2017)
Figure BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales Market Share in United States (2012-2017)
Figure BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Revenue Market Share in United States (2012-2017)
Table Ensemble Therapeutics Corp Basic Information List
Table Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (2012-2017)
Figure Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales Market Share in United States (2012-2017)
Figure Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche Ltd Basic Information List
Table F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Revenue Market Share in United States (2012-2017)
Table Genentech Inc Basic Information List
Table Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (2012-2017)
Figure Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales Market Share in United States (2012-2017)
Figure Genentech Inc Indoleamine 2,3 Dioxygenase 1 Revenue Market Share in United States (2012-2017)
Table Globavir Biosciences Inc Basic Information List
Table Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (2012-2017)
Figure Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales Market Share in United States (2012-2017)
Figure Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Revenue Market Share in United States (2012-2017)
Table Incyte Corp Basic Information List
Table Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (2012-2017)
Figure Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales Market Share in United States (2012-2017)
Figure Incyte Corp Indoleamine 2,3 Dioxygenase 1 Revenue Market Share in United States (2012-2017)
Table IO Biotech ApS Basic Information List
Table IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (2012-2017)
Figure IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales Market Share in United States (2012-2017)
Figure IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Revenue Market Share in United States (2012-2017)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (2012-2017)
Figure Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales Market Share in United States (2012-2017)
Figure Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Revenue Market Share in United States (2012-2017)
Table Netherlands Translational Research Center BV Basic Information List
Table Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (2012-2017)
Figure Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales Market Share in United States (2012-2017)
Figure Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Revenue Market Share in United States (2012-2017)
Table NewLink Genetics Corp Basic Information List
Table Pfizer Inc Basic Information List
Table Redx Pharma Plc Basic Information List
Table Regen BioPharma Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Indoleamine 2,3 Dioxygenase
Figure Manufacturing Process Analysis of Indoleamine 2,3 Dioxygenase
Figure Indoleamine 2,3 Dioxygenase 1 Industrial Chain Analysis
Table Raw Materials Sources of Indoleamine 2,3 Dioxygenase 1 Major Players/Suppliers in 2016
Table Major Buyers of Indoleamine 2,3 Dioxygenase
Table Distributors/Traders List
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Indoleamine 2,3 Dioxygenase 1 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Indoleamine 2,3 Dioxygenase 1 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Indoleamine 2,3 Dioxygenase 1 Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Indoleamine 2,3 Dioxygenase 1 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Indoleamine 2,3 Dioxygenase 1 Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources